Interferon γ- and interleukin-4-secreting cells in multiple sclerosis

[1]  L. Grimaldi,et al.  The hu‐SCID Myasthenic Mouse: A New Tool for the Investigation of Seronegative Myasthenia Gravis a , 1993, Annals of the New York Academy of Sciences.

[2]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[3]  T. Olsson,et al.  Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.

[4]  D. Bourdette,et al.  Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.

[5]  T. Olsson,et al.  Increased numbers of T cells recognizing multiple myelin basic protein epitopes in multiple sclerosis , 1992, European journal of immunology.

[6]  C. Bever,et al.  Upper respiratory tract infections trigger attacks of multiple sclerosis in patients treated with interferon , 1991, Journal of Neuroimmunology.

[7]  J. Convit,et al.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.

[8]  C. Brosnan,et al.  Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. , 1991, Journal of immunology.

[9]  H. Link,et al.  Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis , 1991, Journal of the Neurological Sciences.

[10]  D. Hafler,et al.  Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease. , 1991, Journal of immunology.

[11]  Roberta,et al.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. , 1991, The Journal of clinical investigation.

[12]  J. Trotter,et al.  Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-α levels , 1991, Journal of Neuroimmunology.

[13]  T. Olsson,et al.  Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls , 1991, European journal of immunology.

[14]  M. Piccinni,et al.  Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Olsson,et al.  T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. , 1991, Journal of immunology.

[16]  H. Link,et al.  Anti-presynaptic membrane receptor antibodies in myasthenia gravis , 1991, Journal of the Neurological Sciences.

[17]  T. Mosmann,et al.  Functional diversity of T lymphocytes due to secretion of different cytokine patterns , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  L. Kappos,et al.  Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals , 1990, Neurology.

[19]  L. Kappos,et al.  Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Olsson,et al.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. , 1990, The Journal of clinical investigation.

[21]  G. Delespesse,et al.  Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells , 1989, The Journal of experimental medicine.

[22]  K. Hardy,et al.  Human gamma interferon strongly upregulates its own gene expression in peripheral blood lymphocytes , 1989, The Journal of experimental medicine.

[23]  P. Lipsky,et al.  Immunomodulatory role of IL-4 on the secretion of Ig by human B cells. , 1989, Journal of immunology.

[24]  H. Kirchner,et al.  Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? , 1988, Acta neurologica Scandinavica.

[25]  K. Arai,et al.  IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Lebon,et al.  Multiple sclerosis: Involvement of interferons in lesion pathogenesis , 1988, Annals of neurology.

[27]  O Ouchterlony,et al.  Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. , 1988, Journal of immunological methods.

[28]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[29]  K. Arai,et al.  B cell growth-promoting activity of recombinant human interleukin 4. , 1987, Journal of immunology.

[30]  R. Hirsch,et al.  Treatment of multiple sclerosis with gamma interferon , 1987, Neurology.

[31]  H. Weiner,et al.  Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis , 1986, Journal of Neuroimmunology.

[32]  W. Sibley,et al.  CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS , 1985, The Lancet.

[33]  B. Zweiman,et al.  Isolation of myelin basic protein-reactive T-cell lines from normal human blood. , 1983, Cellular immunology.

[34]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[35]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[36]  C HISCOCK,et al.  YELLOW NAILS AND LYMPHOEDEMA. , 1964, Lancet.

[37]  E. Maggi,et al.  Role of interleukins in induction and regulation of human IgE synthesis. , 1989, Clinical immunology and immunopathology.

[38]  R. Martenson,et al.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. , 1972, Preparative biochemistry.